| Chairman |
|
Xu Min Michael |
| Business Nature |
| 醫療保健 (Health Care) |
| Board Members |
Chairman & General Manager: Xu Min Michael Executive Director: Wang Xiaojun Non-executive Director: Zhou Xiangjun, Xu Yuhong, Zhai Ting, Li Hongkai Independent Non-executive Director: Zhang Jiancun, Chen Yangyang, Fan Xinpeng.
|
| Principle Business |
|
The Group is primarily engaged in research and development of therapies in chronic disease. |
| Major Shareholders |
| Xu Min Michael & ASSO | 46,599,792 | H Sh | 12.07% | 16.69% | 2025/05/27 | | Xu Min Michael & ASSO | 40,657,312 | NON-H SHS | 10.53% | 38.07% | 2025/05/27 | | Mingly China Growth Partners, L.P | 17,426,037 | H Sh | 4.52% | 6.24% | 2025/05/27 | | Mingly China Growth Partners, L.P | 17,426,037 | NON-H SHS | 4.52% | 16.32% | 2025/05/27 |
|
|
|
|
|